Victor Maximov, Ph.D. - Publications
Affiliations: | 2013 | Bioengineering | Clemson University, Clemson, SC, United States |
Area:
Biomedical, Materials Science, NanotechnologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Yun X, Maximov VD, Yu J, Zhu H, Vertegel AA, Kindy MS. Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 583-92. PMID 23385198 DOI: 10.1038/Jcbfm.2012.209 | 0.612 | |||
2011 | Reukov V, Maximov V, Vertegel A. Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents. Biotechnology and Bioengineering. 108: 243-52. PMID 20939007 DOI: 10.1002/Bit.22958 | 0.602 | |||
2011 | Vertegel AA, Reukov V, Maximov V. Enzyme-nanoparticle conjugates for biomedical applications. Methods in Molecular Biology (Clifton, N.J.). 679: 165-82. PMID 20865396 DOI: 10.1007/978-1-60761-895-9_14 | 0.598 | |||
2010 | Maximov VD, Reukov VV, Barry JN, Cochrane C, Vertegel AA. Protein-nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia. Nanotechnology. 21: 265103. PMID 20534889 DOI: 10.1088/0957-4484/21/26/265103 | 0.612 | |||
2009 | Maximov V, Reukov V, Vertegel AA. Targeted delivery of therapeutic enzymes Journal of Drug Delivery Science and Technology. 19: 311-320. DOI: 10.1016/S1773-2247(09)50066-4 | 0.385 | |||
2009 | Yurko Y, Maximov V, Andreozzi E, Thompson GL, Vertegel AA. Design of biomedical nanodevices for dissolution of blood clots Materials Science and Engineering C. 29: 737-741. DOI: 10.1016/J.Msec.2009.01.017 | 0.585 | |||
Show low-probability matches. |